Fig. 4From: Adverse events in single-arm clinical trials with non-fatal time-to-event efficacy endpoint: from clinical questions to methods for statistical analysisa) \(CI_{ON}(t)\) estimated through the AJ formula; b) \(AN_{ON}(t)\) and \(KM_{ON}(t)\) step curves of the cumulative \(CSH_{ON}(t)\) and of the cumulative incidence of ON, respectivelyBack to article page